Article in ACR open rheumatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors.
Andriko PalmowskiSection for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen University Hospital, Copenhagen, Denmark and Department of Rheumatology and Clinical Immunology and Berlin Institute of Health, Charité - Universitätsmedizin Berlin and Epidemiology and Health Services Research, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin, Germany.ORCID https://orcid.org/0000-0002-3456-0597
Frank ButtgereitDepartment of Rheumatology and Clinical Immunology Charité - Universitätsmedizin Berlin and Translational Rheumatology, German Rheumatism Research Center (DRFZ), A Leibniz Institute, Berlin, Germany.ORCID https://orcid.org/0000-0003-2534-550X
David SimonDepartment of Rheumatology and Clinical Immunology Charité - Universitätsmedizin Berlin and Translational Rheumatology, German Rheumatism Research Center (DRFZ), A Leibniz Institute and Fraunhofer Institute for Translational Medicine and Pharmacology, Allergology and Immunology Berlin, Germany and Department of Internal Medicine 3, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen and Deutsches Zentrum Immuntherapie, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany.
Arnd KleyerDepartment of Rheumatology and Clinical Immunology Charité - Universitätsmedizin Berlin, Berlin, Germany.
Norman Michael DrzeniekDepartment of Rheumatology and Clinical Immunology Charité - Universitätsmedizin Berlin and BIH Center for Regenerative Therapies, Berlin Institute of Health at Charité - Universitätsmedizin Berlin, Berlin, Germany.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.
Tofacitinib-Induced Weight Gain in Context: comment on the article by Wollenhaupt et al. · full record | Socratic